Decreased diacylglycerol metabolism enhances ERK activation and augments CD8+ T cell functional responses.
Modulation of T cell receptor signal transduction in CD8(+) T cells represents a novel strategy toward enhancing the immune response to tumor. Recently, levels of guanine exchange factors, RasGRP and SOS, within T cells have been shown to represent a key determinant in the regulation of the analog to the digital activation threshold of Ras. One important for regulating activation levels of RasGRP is diacylglycerol (DAG), and its levels are influenced by diacylglycerol kinase-ζ (DGKζ), which metabolizes DAG into phosphatidic acid, terminating DAG-mediated Ras signaling. We sought to determine whether DGKζ-deficient CD8(+) T cells demonstrated enhanced in vitro responses in a manner predicted by the current model of Ras activation and to evaluate whether targeting this threshold confers enhanced CD8(+) T cell responsiveness to tumor. We observed that DGKζ-deficient CD8(+) T cells conform to most predictions of the current model of how RasGRP levels influence Ras activation. But our results differ in that the EC(50) value of stimulation is not altered for any T cell receptor stimulus, a finding that suggests a further degree of complexity to how DGKζ deficiency affects signals important for Ras and ERK activation. Additionally, we found that DGKζ-deficient CD8(+) T cells demonstrate enhanced responsiveness in a subcutaneous lymphoma model, implicating the analog to a digital conversion threshold as a novel target for potential therapeutic manipulation.
Abramson Family Cancer Research Institute, Department of Medicine, University of Pennsylvania Philadelphia, Pennsylvania 19104, USA.
Matthew J
MJ
Riese
Jashanpreet
J
Grewal
Jayajit
J
Das
Tao
T
Zou
Vineet
V
Patil
Arup K
AK
Chakraborty
Gary A
GA
Koretzky
D000818:Animals; D018414:CD8-Positive T-Lymphocytes / Q000201:enzymology / Q000276:immunology* / Q000378:metabolism; D019852:Diacylglycerol Kinase / Q000235:genetics / Q000276:immunology* / Q000378:metabolism; D004075:Diglycerides / Q000235:genetics / Q000276:immunology* / Q000378:metabolism; D004789:Enzyme Activation / Q000235:genetics / Q000276:immunology; D048049:Extracellular Signal-Regulated MAP Kinases / Q000235:genetics / Q000276:immunology* / Q000378:metabolism; D008223:Lymphoma / Q000201:enzymology / Q000235:genetics / Q000276:immunology* / Q000628:therapy; D051379:Mice; D018345:Mice, Knockout; D018448:Models, Immunological; D009374:Neoplasms, Experimental / Q000201:enzymology / Q000235:genetics / Q000276:immunology* / Q000628:therapy; D018631:ras Proteins / Q000276:immunology / Q000378:metabolism
D004075:Diglycerides; D019852:Diacylglycerol Kinase; C512480:diacylglycerol kinase zeta, mouse; D048049:Extracellular Signal-Regulated MAP Kinases; D018631:ras Proteins